Professional Documents
Culture Documents
Carbohydrate Metabolism Disorders Stom 10-11
Carbohydrate Metabolism Disorders Stom 10-11
General etiopathogenesis of metabolic disorders Disorders of carbohydrate metabolism Hyper-, hypoglycemic states Diabetes mellitus as a model of metabolic disorders
5.
6. 7. 8. 9.
2. Damage to membrane and intracellular receptors signal pathology 3. Impairment in endocrine (humoral) regulation
impairment in enzyme synthesis and activation
3
4. Impairment of neural control a) Impairment of trophic function (via axoplasmic influence) b) emotional stress impairment of limbic-cortical regulation c) impairment in secretion of hypothalamic releasing hormones d) disorders of vegetative nervous system
Memory Check!
Blood glucose homeostasis (balance) regulation
inhibition activation
Permeability
of
Insulin
glycolytic enzymes
gluconeogenesis
glucose-6phosphate production
6
3.85
Hypoglycemia
6.05
NORM
Hyperglycemia
GLUCOSE
7
Hypoglycemia
Exogenous Endogenous
Functional
Exogenous hypoglycemia
consumption)
Some drugs (e.g. salicylates, pentamidine) Long term and intense physical exercise
9
Endogenous hypoglycemia
insulinoma (hyperplasia of -cells) glycogenosis (glycogen storage disease) hereditary fructose intolerance
2. Spontaneous reactive (cause is not known diarrhea, tachycardia, tremor, headache, weakness) 3. Alcohol promoted (consumption in hungry state)-drinking on an empty stomach 4. Endocrine insufficiency (decrease in counter-insulin hormone ) 5. Hepatic failure 6. Malnutrition (lack of body stores for protein, fat, carbohydrates) 7. Heavy physical load (without carbohydrate uptake) 8. Transient functional hypoglycemia of children (in infancy) Neonatal (10% of live births, during first 3 days of life) Maternal diabetes (caused by B-cell hyperplasia) Erythroblastosis fetalis (incompatibility between maternal 11
Manifestations of hypoglycemia Starvation Tremor Excessive sweating Tachycardia Headache, dizziness-term for describing various symptoms (faintness, giddiness, unsteadiness) Impaired vision Anxiety, fear Impaired cognition
12
Hyperglycemia
4. Epinephrine
5.ACTH
Mechanisms:
A. release of corticosteroids liver gluconeogenesis & glycogenolysis
13
Hyperglycemia
Causes of hyperglycemia (excessive glucose in the blood)
Manifestations of hyperglycemia
Glucosuria
Polyuria
Polydypsia Hypohydration of the organism
Arterial hypotension
15
Diabetes mellitus
The term diabetes mellitus (DM, from going through and honey, sweet) is used to describe a syndrome characterized by chronic hyperglycemia and other disturbances of carbohydrate, fat, and protein metabolism.
16
Non-enzymatic glycosylation
17
Role of
1. I N S U LI N
1. Increase in permeability of myocyte and adipocyte membranes for glucose (Glut-4) 2. Increase in activity of glucokinase, glycogensythetase, aerobic glycolysis, pentose-phosphate shunt and Krebs cycle enzymes 3. Increased rate of glycogen synthesis in liver 4. Increase in synthesis of lipids from glucose 5. Inhibition of gluconeogenesis
All the mentioned mechanisms are impaired with insulin 18 deficiency in DM and cause hyperglycemia.
2. Counter-insulin hormones A CTH, growth hormone, cortisol, thyroid hormone, glucagon, adrenaline
1.Stimulate absorption of carbohydrates (cortisol, thyroid hormone) 2. Increase glycogenolysis in liver and muscles, inhibit glycogenesis ( adrenaline, cortisol, thyroid) 3. Inhibit hexokinase activity and therefore its utilization (cortisol, growth hormone) 4.Stimulate gluconeogenesis (cortisol, thyroid, glucagon) 5. Activate insulinase (growth hormone, thyroid)
Immune-mediated
Idiopathic
20
Classification of DM Most common are: 1: -cell defect or failure Juvenile, Insulin-dependent diabetes mellitus (IDDM)
Type Type
2: Insulin resistance with inadequate Insulin secretion-Adult onset diabetes mellitus Non insulin dependent diabetes mellitus (NIDDM)
22
Pancreatic islet
1.
2.
1. 3.
3. 4. 5.
6.
Insulin Independent * 4. Months to years 5. Chronic Vascular 6. No Yes 8. Normal or high * 9. Normal / Exhaustion 10.60-80% in twins 11.No
7.
25
7. 8.
9.
10. 11.
Type 1 DM results from autoimmune destruction of -cells and is related to genetic susceptibility, autoimmunity and environmental factors. Autoimmunity is resulted by -cell antibodies and antibodies to insulin, glutamic acid decarboxylase that participate in damage of -cell. Clinical manifestations and mechanisms for DM-1: Hyperglycemia- see previous information. Polyuria - hyperglycemia acts as an osmotic diuretic. Glucosuria - the glucose filtration exceeds reabsorption by the renal tubules. Polydipsia - elevated blood sugar level is resulted in water loss (osmotically attraction) from body cells dehydration stimulation of thirst in hypothalamus. Polyphagia - depletion of cellular stores of carbohydrates, fats and proteins cellular starvation increase in hunger. Proteins and fats break down weight loss. Ketoacidosis is caused by increased metabolism of fats and proteins 26 ketones pH metabolic acidosis.
Type 1 DM
1.
2.
It occurs secondary to other diseases (such as pancreatitis or to a more fulminate disorder termed idiopathic (type 1B) DM)
27
Autoantigens on -cells
Circulate in blood stream and lymphatics
Presentation of autoantigen
Activation of Th1 lymphocytes
IFN-
28
Genetic HLA-DR3/4
Pathogenesis of Type 1 DM
Environment Viral infe..? Autoimmune Insulitis Ab to cells/insulin
1. Drugs, chemicals (streptozotocin, alloxan, pentamidine) 2. Dietary (cow milk, high nitrosamine levels) 3. Viruses (Coxsackie, measles, rubella, cytomegalovirus) (molecular mymicry)
cell Destruction
Insulin deficiency
Type 1 / IDDM
By lymphocytes islet cell autoantibodies and/or autoantibodies to insulin, glutamic acid decarboxylase (GAD) and tyrosine 29 - phosphatase.
Type 2 DM
Type 2 DM results from a combination of genetic and environmental factors: Genetic involves genes that influence cellular responses to insulin or -cell function, or both. Decreased -cell responsiveness to plasma glucose levels. Islet dysfunction due to decrease in -cell mass and abnormal function, amyloid deposits cell destruction.
Glossary
b)
c)
Leptin decrease insulin sensitivity Resistin Adiponectin Amylin-is a hormone co-secreted with insulin by the -cells, inhibits glucagon secretion (deficiency of amylin in type 1, type 2 DM). Incretins-are a class of peptides released from the gastrointestinal tract in response to food intake, bind to receptors on -cells and increase secretion of insulin in response to glucose level. Ghrelin-is a peptide produced in the stomach and pancreatic islets that stimulates GH receptors. Decreased level of ghrelin is associated with insulin resistance. Fatty acids increase in DM attenuates insulin signaling. 31
Obesity
Insulin resistance
Diabetes
Type 2 DM
How obesity is related with DM-2?
Obesity
lipid accumulation in islets. excess fat in muscle insulin resistance. fat infiltration in the liver
-cells
are sensitive to high levels of glucose and free fatty acids and undergo apoptosis. Cytokines (TNF, IL-1) also are toxic to -cells. Amylin is decreased.
Down
33
regulation of insulin receptors. Postreceptor insulin signaling is impaired. Disrupt insulin signaling insulin resistance hyperinsulinemia.
Pathogenesis of Type 2 DM
Genetic / cell defect Obesity / Life style ? Abnor. Secretion Insulin Resistance
Note! In type 2 DM combination of insulin resistance and -cell dysfunction relative insulin deficiency.
IDDM
cell exhaustion
Pathogenesis of Type 2 DM
Genetic predisposition
activity of genes that code amylin
Obesity
adipokines, free fatty acids, -cell mass inflamm. cytokines (TNF-, IL-1), and function ghrelin activity activity of
incretins
MAIN IMPAIRMENT IN DM
HYPERGLYCEMIA
(mechanisms - see effects of insulin) Hyperglycemia is a main underlying characteristic for all metabolic disorders and damage of multiple organs in DM.
36
Insulin insufficiency
Fatty acids
Ketone bodies
- hydroxybutirate, acetoacetate accumulation in blood
Metabolic acidosis
Ketonuria
Kussmaul's respiration
CNS depression
SHOCK
Stress hormones
Catecholamines, cortisol, growth hormone, glucagon Hyperglycemia
38
I. Acute:
Coma
Keto-acidotic
Hyperosmolar, Hyperglycemic
Lactate-acidotic
1) Microangiopathy
2) Macroangiopathy
Macroangiopathy
Macroangiopathy - result of atherosclerotic
Neuropathies
Are associated with hyperglycemia due to three metabolic events: non enzymatic glucosylation, polyol pathway and protein kinase C activation.
41
Chronic Polyneuropathy
Claw foot Dermopathy & Neuropathy
44
45
Neuropathic ulcer
Etiology: peripheral sensory neuropathy, Trauma & deformity. Factors: Ischemia, callus formation, and edema.
46
Typical tests 1. Choose the exogenous cause of hypoglycemia 1) Glycogenosis 2) Hyperplasia of -sells 3) High doses of insulin 4) Defficiency of phosphoenolpyruvatee carboxy-kynase 2. Hypoglycemia is a characteristic finding in: a) gastrinoma, b) insulinoma, c) glucagonoma, d) VIPoma. 3. The following statements are true concerning insulin-dependent diabetes, EXCEPT: a) there is association with HLA-DR3, HLA-DR4, b) there is autoimmune disease association, c) there is more than 90% concordance for monozygotic twins to develop diabetes d) viral infection may precede type I diabetes. 47
4. The following are correct statements for type II diabetes, EXCEPT: a) It is more than common than IDDM, b) These patients are generally obese. c) Insulin resistance plays an important role. d) There is presence of insulitis. 5. The following complication is almost exclusive for type I diabetes (IDDM): a) hyperosmolar coma, b) atherosclerosis, c) diabetic ketoacidosis, d) diabetic nephropathy. 6. The most reliable assessment of diabetes is provided by the following investigation. a) whole blood glucose estimation, b) plasma glucose estimation, c) capillary method of glucose estimation, d) glycosylated hemoglobin.
48
7. Which of the following is not an acute complication of diabetes: 1) hypoglycemic coma, 2) ketoacidotic coma, 3) hyperglycemic coma, 4) retinopathy. 8. Choose the chronic (late) complications of diabetes: a) neuropathy, b) nephropathy c) hypoglycemic coma, d) atherosclerosis, e) hyperosmolar coma. Choose the correct answer: 1-a,b,d 2-a,d,e 3-c,d,e
4-a,b
9. Which statement is the most correct: 1) Diabetes mellitus is a chronic systemic disease which is characterized by hyperglycemia. 2) Diabetes mellitus is a hyperglycemic state is caused by an autoimmune reaction triggered by an infection. 3) Diabetes mellitus is a chronic systemic disease which is characterized by insulin deficiency or peripheral resistance, resulting in hyperglycemia, disorders of 49 carbohydrates, protein, lipid metabolism.
10. Choose the typical presentations of type I diabetes mellitus: a) polydipsia, polyuria and polyphagia, b) dehydration, c) obesity, d) hyperosmolar coma, e) metabolic ketoacidosis. Choose the correct answer: 1-a,b,c 2-a,d,e 3-a,b,e 4-a,d,c 11. All of the following are characteristics of type II diabetes mellitus (DM),EXCEPT: 1) Represents 90% of causes DM, 2) Affects obese adults usually older than 30 years, 3) Relative insulin insufficiency, 4) Metabolic ketoacidosis, 5) Hyperglycemia. 12. Which of the following disorders in oral cavity is associated with DM? a) Delayed wound healing b) Destruction of parodentium c) Activation of infections d) All of the above.
50
ADDITIONAL SLIDES
51
Adipose tissue
Liver
Muscle
Lypolysis Ketogenesis Glucogen Synthesis FFA Gluconeogenesis Glycerol Protein catabolism Hyperglycemia LDL cholesterol Aminoacids Glucosuria HDL Ketoacidosis Muscle wasting Osmotic diures Loss of water and electrolytes Hypovolemia
Hyperventilation
Hypotension
Death
52
Pathophysiology of Type 2 DM
central obesity
Genetic predisposition Diet, physical inactivity
Cardiovascular disease
Insulin deficiency
Decreased glucose utilization Increased glucose production Hyperglycemia Glucosuria Osmotic diuresis
SHOCK
54
Hyperlipidemia
Metabolic acidosis Ketonemia and hypercholesterolem ia Keto-acidotic coma Increased ketogenesis and cholesterol productoin Ketonuria Loss of Na+
55
56
Whats New
Metabolic syndrome
The metabolic syndrome also has been called the Insulin resistance syndrome or syndrome X. It is a clustering of clinical traits occurring together that increase the risk for accelerated cardiovascular disease and type 2 DM. Metabolic syndrome was recently defined by the National Cholesterol Education Programs Adult Treatment Panel III as the identification of three of the following five traits: Increase waist circumference (>40 inches, > 35 woman) Plasma triglycerides >15mg/dl Plasma HDL cholesterol <40mg/dl , <50 mg/dl Blood pressure > 130/85 mm Hg Fasting plasma glucose > 100mg/dl
The syndrome is associated with insulin resistance and behaviorally modifiable risk factors, such as smoking, exercise and diet.
57
Non-Enzymatic glycosylation
Irreversible Advanced Glycosylation End products (AGE) formation. Non-enzymatic glycosylation is the reversible attachment of glucose to protein, lipid, nucleic acids, Hb, collagen, long life span proteins, without action of enzymes damage to interstitial space, vessels a) Basal membranes thickening b) Binding of different cell receptors (such as macrophages) c) Immune complex formation d) Increased production of endothelins, cytokines vasoconstriction, thrombosis e) Induction of oxidative stress (free radicals) f) Inactivation of NO (loss of vasodilation) g) Procoagulant changes on endothelial cells. 59
59
hyperglycemia
B) Polyol pathway (alternate metabolic pathway of glucose)
Glucose is shunted and converted to sorbitol (a polyol) by aldose reductase and to fructose (by sorbitol dehydrogenase).
Accumulation of sorbitol and fructose Increase in intracellular osmotic pressure Water influx and swelling, cell injury
hyperglycemia
C) Protein kinase C (PKC) pathway activation
PKC is a family of different intercellular signaling proteins.
Consequences:
Insulin resistance
Production of extracellular matrix and cytokines Vascular cell proliferation Enhanced contractility Increased permeability